Actively Recruiting
Prospective Registry of Histotripsy for Soft Tissue Tumors
Led by University of California, San Francisco · Updated on 2026-03-17
200
Participants Needed
1
Research Sites
52 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are studying the use of histotripsy, a treatment that applies focused ultrasound waves to break down soft tissue tumors without surgery. This prospective observational registry aims to collect information on the safety and effectiveness of histotripsy in treating soft tissue neoplasms and cancers. The study will assess tumor response using standardized imaging criteria and monitor survival outcomes and adverse events over time. Participants receive histotripsy as part of their standard clinical care at the University of California, San Francisco. The study does not involve any additional treatments or interventions but collects data from medical records following the procedure. This includes details of the histotripsy treatment, cancer history, laboratory results, adverse events, and demographic information. Data collection occurs over three years after the histotripsy procedure, gathering information during participants' regular doctor visits. Researchers will evaluate tumor response, progression-free survival, overall survival, and any adverse events using established criteria. The registry focuses on real-world outcomes and safety monitoring without requiring extra visits or procedures beyond standard care.
CONDITIONS
Brief Title
Prospective Registry of Histotripsy for Soft Tissue Tumors
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adult patients treated with histotripsy as part of standard clinical care at University of California San Francisco (UCSF)
You will not qualify if you...
- Children and minors
- Adults lacking the capacity to make medical decisions
- Patients who do not consent to inclusion in the registry
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 3 years
Participants who have undergone the histotripsy procedure are observed through collection of data from their regular doctor visits including tumor response, adverse events, and survival outcomes.
Data collected during routine medical visits
Trial Site Locations
Total: 1 location
1
University of California, San Francisco
San Francisco, California, United States, 94143
Actively Recruiting
Research Team
R
Ryan Lokken, MD
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here